Literature DB >> 11161631

Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in the rat: modulation by nitecapone, a COMT inhibitor with antioxidant properties.

A Pertovaara1, H Wei, J Kalmari, M Ruotsalainen.   

Abstract

We attempted to characterize a spinal neuronal correlate of painful neuropathy induced by diabetes mellitus (DM). Pain behavior and response properties of spinal dorsal horn neurons were determined in rats with a streptozocin-induced DM. A catechol-O-methyltransferase inhibitor with potent antioxidant properties, nitecapone, was used in an attempt to attenuate neuropathic symptoms. Behaviorally DM induced mechanical hypersensitivity that was markedly attenuated by oral treatment with nitecapone. The antihyperalgesic effect of nitecapone was not reversed by naloxone, an opioid antagonist, or atipamezole, an alpha-2-adrenoceptor antagonist. Electrophysiological recordings performed in pentobarbitone-anesthetized animals revealed that the most distinct abnormality in response properties of spinal dorsal horn wide-dynamic range (WDR) neurons was the increase in their spontaneous activity observed in untreated but not in nitecapone-treated DM rats. Conditioning electrical stimulation and a lidocaine block of the rostroventromedial medulla (RVM) had a similar modulatory effect on evoked responses of spinal dorsal horn WDR neurons in all experimental groups. The response properties of spinal dorsal horn nociceptive-specific or low-threshold mechanoreceptive neurons were not markedly different between the experimental groups. The results indicate that increased spontaneous activity in spinal dorsal horn WDR neurons may be causally related to behaviorally observed mechanical hypersensitivity in DM. Attenuation of the increased spontaneous activity in WDR neurons may explain the antihyperalgesic effect by nitecapone, due to naloxone- and alpha-2-adrenoceptor-insensitive mechanisms. DM or nitecapone treatment did not produce significant changes in phasic or tonic descending pain regulation originating in the RVM. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161631     DOI: 10.1006/exnr.2000.7574

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  33 in total

1.  Inhibitors of catechol-O-methyltransferase sensitize mice to pain.

Authors:  O Kambur; R Talka; O B Ansah; V K Kontinen; A Pertovaara; E Kalso; P T Männistö
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

2.  Maladaptive dendritic spine remodeling contributes to diabetic neuropathic pain.

Authors:  Andrew M Tan; Omar A Samad; Tanya Z Fischer; Peng Zhao; Anna-Karin Persson; Stephen G Waxman
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

3.  Changes in the basal membrane of dorsal root ganglia Schwann cells explain the biphasic pattern of the peripheral neuropathy in streptozotocin-induced diabetic rats.

Authors:  Maria Becker; Tali Benromano; Abraham Shahar; Zvi Nevo; Chaim G Pick
Journal:  J Mol Neurosci       Date:  2014-09-27       Impact factor: 3.444

4.  Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.

Authors:  Olga Ilnytska; Valeriy V Lyzogubov; Martin J Stevens; Viktor R Drel; Nazar Mashtalir; Pal Pacher; Mark A Yorek; Irina G Obrosova
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

5.  Characterization of upper thoracic spinal neurons receiving noxious cardiac and/or somatic inputs in diabetic rats.

Authors:  Marie Louise M Ghorbani; Chao Qin; Mingyuan Wu; Jay P Farber; Majid Sheykhzade; Bjarne Fjalland; Niels C B Nyborg; Robert D Foreman
Journal:  Auton Neurosci       Date:  2011-09-08       Impact factor: 3.145

Review 6.  Future treatments for diabetic neuropathy: clues from experimental neuropathy.

Authors:  Nigel A Calcutt
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

7.  Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor.

Authors:  N A Calcutt; J D Freshwater; A P Mizisin
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

Review 8.  Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Authors:  Irina G Obrosova
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  Functional magnetic resonance imaging of the spinal cord during sensory stimulation in diabetic rats.

Authors:  Krisztina L Malisza; Cheryl Jones; Marco L H Gruwel; Derek Foreman; Paul Fernyhough; Nigel A Calcutt
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

10.  PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.

Authors:  Irina G Obrosova; Weizheng Xu; Valeriy V Lyzogubov; Olga Ilnytska; Nazar Mashtalir; Igor Vareniuk; Ivan A Pavlov; Jie Zhang; Barbara Slusher; Viktor R Drel
Journal:  Free Radic Biol Med       Date:  2007-10-03       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.